CellSeed Statistics

Total Valuation

CellSeed has a market cap or net worth of JPY 17.85 billion.

Market Cap	17.85B
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CellSeed has 34.67 million shares outstanding.

Current Share Class	34.67M
Shares Outstanding	34.67M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	3.56%
Owned by Institutions (%)	-10.22%
Float	32.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	110.89
PB Ratio	17.40
P/TBV Ratio	17.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.36, with a Debt / Equity ratio of 0.15.

Current Ratio	6.36
Quick Ratio	5.95
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -71.66% and return on invested capital (ROIC) is -37.67%.

Return on Equity (ROE)	-71.66%
Return on Assets (ROA)	-33.81%
Return on Invested Capital (ROIC)	-37.67%
Return on Capital Employed (ROCE)	-70.90%
Revenue Per Employee	3.66M
Profits Per Employee	-20.77M
Employee Count	44
Asset Turnover	0.10
Inventory Turnover	2.36

Taxes

In the past 12 months, CellSeed has paid 3.00 million in taxes.

Income Tax	3.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.66% in the last 52 weeks. The beta is 0.80, so CellSeed's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+107.66%
50-Day Moving Average	535.16
200-Day Moving Average	536.56
Relative Strength Index (RSI)	45.73
Average Volume (20 Days)	1,161,190

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellSeed had revenue of JPY 161.00 million and -914.00 million in losses. Loss per share was -53.15.

Revenue	161.00M
Gross Profit	63.00M
Operating Income	-865.00M
Pretax Income	-911.00M
Net Income	-914.00M
EBITDA	-863.00M
EBIT	-865.00M
Loss Per Share	-53.15

Full Income Statement

Balance Sheet

The company has 930.00 million in cash and 159.00 million in debt, giving a net cash position of 771.00 million or 22.24 per share.

Cash & Cash Equivalents	930.00M
Total Debt	159.00M
Net Cash	771.00M
Net Cash Per Share	22.24
Equity (Book Value)	1.03B
Book Value Per Share	57.77
Working Capital	922.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -817.00 million and capital expenditures -91.00 million, giving a free cash flow of -908.00 million.

Operating Cash Flow	-817.00M
Capital Expenditures	-91.00M
Free Cash Flow	-908.00M
FCF Per Share	-26.19

Full Cash Flow Statement

Margins

Gross Margin	39.13%
Operating Margin	-537.27%
Pretax Margin	-565.84%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CellSeed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.34%
Shareholder Yield	n/a
Earnings Yield	-5.12%
FCF Yield	-5.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CellSeed has an Altman Z-Score of 0.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.24
Piotroski F-Score	2